COMMUNIQUÉS West-GlobeNewswire

Genmab Announces Abstracts to be Presented at 23rd EHA Annual Congress
17/05/2018
Media Release Seven industry sponsored abstracts regarding Genmab programs scheduled for presentation at EHA Annual Congress Two oral presentations, five poster presentations Copenhagen, Denmark; May 17, 2018 – Genmab A [...]
Active Biotech AB Interim report January - March 2018
17/05/2018
First quarter in brief Decision on new share issue with preferential rights for shareholders taken at Extraordinary General Meeting on March 19, 2018 Patent application for tasquinimod for the treatment of multiple [...]
NanoVibronix Provides Business Update for the First Quarter 2018
17/05/2018
ELMSFORD, N.Y., May 17, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV ) , a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today [...]
FIT Biotech Oy: FIT Biotech Ltd's own equity negative in the end of April - FIT Biotech Ltds' equity will be positive with draw down of the fourth tranche
17/05/2018
FIT Biotech Oy Company release May 17, 2018 at 4:30 pm EET FIT Biotech Ltd's own equity negative in the end of April - FIT Biotech Ltds' equity will be positive with draw down of the fourth tranche The Company's own [...]
Healthcare Administrative Technology Association (HATA) Puts Forth Bold Recommendations Regarding NCVHS Predictability Roadmap
17/05/2018
Association calls for business needs and ROI validation, an emerging trend monitoring organization, standard transaction usage requirements, and data harmonization LAGUNA BEACH, Calif., May 17, 2018 (GLOBE NEWSWIRE) -- [...]
Abattis Signs Agreement with Cannamedix to Support the Development and Commercialization of CBD-infused Natural Health Products
17/05/2018
VANCOUVER, British Columbia, May 17, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the " Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to announce it has entered into a non-binding letter of intent ( [...]
Bellicum Announces Clinical Presentations on Lead Product Candidate BPX-501 at the 23rd Congress of the European Hematology Association
17/05/2018
Oral and poster presentations highlight BPX-501 data in pediatric patients with PIDs and AML HOUSTON, May 17, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM ), a leader in developing novel, [...]
Abeona Reports Update from EB-101 Gene Therapy in Epidermolysis Bullosa at 21st Annual ASGCT Meeting
17/05/2018
Phase 1/2 Study Update Confirms EB-101 is Safe and Well-tolerated, with Durable Efficacy NEW YORK and CLEVELAND, May 17, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical-stage [...]
Olainfarm Sales In The First 4 Month Face 8% Increase
17/05/2018
Olainfarm Sales In The First 4 Month Face 8% Increase Consolidated Results April and 4 Months of 2018 Preliminary consolidated results of JSC Olainfarm for April 2018 show that Groups’ sales in April reached 11,03 [...]
UPDATE: PotNetwork Holdings’ Diamond CBD Giving Away 25,000 Assorted Gummy Bear Samples at CHAMPS Atlantic City 2018
17/05/2018
Set to Make a Dominating Impact Through the Mass Circulation of Diamond CBD’s Increasingly Popular Edibles, the Company Gives Away Samples of one of its Fastest Growing Product Lines to Vendors at the World’s Most [...]
Epizyme to Present New Tazemetostat Data at the American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) Congress
17/05/2018
Company to Host Investor Conference Call Today at 9:30 a.m. EDT CAMBRIDGE, Mass., May 17, 2018 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ: EPZM ), a clinical-stage company developing novel epigenetic therapies, announced [...]
TG Therapeutics, Inc. Announces Upcoming Data Presentations at the 54th Annual Meeting of the American Society of Clinical Oncology and the 23rd Congress of the European Hematology Association
17/05/2018
NEW YORK, May 17, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX ), today announced that abstracts featuring umbralisib (TGR-1202), the Company's once-daily PI3K delta inhibitor, and TG-1701, the Company’s [...]
Geron Announces Oral Presentation at European Hematology Association Congress
17/05/2018
Updated Imetelstat Clinical Data from Part 1 of IMerge in Myelodysplastic Syndromes to be Presented MENLO PARK, Calif., May 17, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN ) today announced that an abstract [...]
HempAmericana Begins Bottling and Distribution Phase for 99% Pure CBD Isolate Production
17/05/2018
NEW YORK, May 17, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire – HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is excited to announce that it is in the final testing stage of specialized bottling [...]
Novartis data at ASCO and EHA reinforce company's commitment to reimagining cancer
17/05/2018
Results from the Kisqali ® MONALEESA clinical trial program, the largest industry- sponsored Phase III registration program researching a CDK4/6 inhibitor in HR+/HER2- advanced breast cancer, will be presented at ASCO [...]
Ceapro Inc. Reports 2018 First Quarter Results
17/05/2018
EDMONTON, Alberta, May 17, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO ) (“Ceapro” or the “Company”) , a growth-stage biotechnology company focused on the development and commercialization of active ingredients for [...]
Atara Biotherapeutics to Present Long-Term Tab-cel™ Phase 2 Clinical Outcomes for Patients with Epstein-Barr Virus Associated Post-Transplant Lymphomas at 23rd Congress of European Hematology Association
17/05/2018
SOUTH SAN FRANCISCO, Calif., May 17, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Trading by management and close relations of management
17/05/2018
Read the full announcement in the attached file Attachment 2018_34_Trading_by_management_EN
SELLAS Life Sciences to Present Phase 1/2 Clinical Data of Galinpepimut-S (GPS) in Ovarian Cancer at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
17/05/2018
Clinical and Regulatory Advisory Board Meetings for NeuVax in Triple Negative Breast Cancer on May 30, and May 31, 2018 NEW YORK, May 17, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc., (Nasdaq: SLS ) (SELLAS [...]

Pages